Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to glp-1 receptor agonist treatment

HIGHLIGHTS

• who: Erik Stenberg from the (UNIVERSITY) have published the article: Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to GLP-1 receptor agonist treatment, in the Journal: (JOURNAL) of 20/01/2023
• what: The aim of this study was to assess the impact of MBS on CVD outcomes in patients with severe obesity and T2D compared to non-surgical patients with T2D treated with GLP-1 RA. Patients treated with MBS in this study had a mean total weight-loss of 25.9 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.